The University of Hong Kong is set to launch a new osteoporosis screening program in pharmacies across the city starting early next year. The initiative, led by the Li Ka Shing Faculty of Medicine, aims to identify individuals at high risk of osteoporosis through a specialized screening algorithm used by pharmacists during routine visits. High-risk patients will then be referred to family doctors for further testing, including bone density scans. Osteoporosis affects approximately 30% of women and 8% of men over the age of 50 in Hong Kong, but most cases remain undiagnosed due to the disease being asymptomatic until a fracture occurs. Hip fractures carry a high mortality rate, with nearly half of affected patients not surviving past five years, often due to complications like pneumonia resulting from prolonged immobility.
Bias read (Center): The article discusses a health initiative focused on osteoporosis screening, which is not inherently politically charged. It provides factual information about the program, its goals, and the medical context surrounding osteoporosis without showing any clear ideological bias or framing that favors a





